GMP for Herbal Medicinal Products (HMPs) + Post Conference on Qualification & Validation Aspects for Cannabis - Live Online Conference

8/9 November 2022

Course No. 20172

header-image

Note: All times mentioned are CET. For participants of the post-conference only- Every participant will receive the printed version of ECA´s Cannabis Roadmap - Global GMP Requirements and Regulatory Information on Medicinal Cannabis (and CBD Products)!- Non-official English translations of the German Pharmacopoeia (DAB) Monographs Cannabis flower and Cannabis Extract for download

Objectives

The course will provide you with the necessary GMP/GACP knowledge for Herbal Drugs, Herbal Drug Preparations (e.g. Extracts) and Herbal Medicinal Products (HMPs). This includes regulatory & quality requirements as well as applicable pharmacopoeial monographs and challenges often encountered in HMPs, e.g. during stability studies.

In addition, more and more countries around the world legalize cannabis for medical use. But what qualifies as medical grade cannabis? And which aspects have to be considered in particular during Qualification/Validation? The dedicated Post-conference will provide you with the necessary details for medical cannabis products.

Background

Herbal Medicinal Products are accepted and widely-used remedies. Although several routes exist for HMPs to receive a marketing authorization, e.g. well-established or traditional use – or special cases like medical cannabis as “Formula magistralis / officinalis” without marketing authorization - they all need to fulfill the same pharmaceutical quality standards. However, HMPs have some very specific characteristics that must be taken into consideration for GMP compliant production, quality control, release and stability testing. Questions often raised include the following:
  • Which contaminants have to be considered?
  • Which microbiological provisions apply?
  • Which kind of decontamination procedures can be used?
  • Are there different requirements for herbal drugs, herbal
drug preparations (like extracts) and the final HMP? To provide more detailed information on these requirements, the European Medicines Agency (EMA) recently published the final guidelines (Revision 3) on quality and specifications for herbal medicinal products (HMPs). Amongst others, a written GACP confirmation for the herbal substance should be provided either by the herbal drug supplier or the manufacturer of the active substance / the HMP. In addition, EMA´s HMPC is currently working on the revision of the GACP guideline and recently already published a concept paper.

Moreover, Qualification and Validation is an essential GMP requirement. Non-EU suppliers, who currently produce according to GPP, will have to implement EU-GMP standards if they want to supply herbal drugs like medical cannabis to the EU market. But which requirements apply? And what does it mean in practice? The post-conference will specifically answer these questions and provide you with practical examples.

Target Group

This course is designed for all people in pharmaceutical and API industry’s quality control, regulatory affairs, pharmacovigilance, production and purchasing departments who need to establish, monitor and/or manage the quality of Herbal Drugs / Herbal Medicinal Products. The post-conference specifically addresses Qualification/Validation aspects to consider for Growers, Manufacturers, Start-Ups, Suppliers, Importers, Wholesalers, QPs and QA/QC personnel involved in Cannabis production.

Technical Requirements

We use Webex Events for our live online training courses and webinars. At https://www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.

Programme

GMP for Herbal Medicinal Products (HMPs) + Post Conference on Qualification & Validation Aspects for Cannabis - Live Online Conference

Seminar Programme as PDF

GMP for Herbal Medicinal Products(HMPs)
 
Programme - 8 November 2022
 
The Regulatory Framework for HMPs
  • Definitions
  • Marketing authorization and registrati„on
  • Particularities of Traditional Herbal Medical Products
  • Quality aspects and GACP confirmation
Quality Requirements for Marketing Authorization Applications
  • Borderline GACP-GMP
  • Types of extracts
  • Control strategy for extracts and drug products
  • Context with clinical data and regulatory pathway
  • Is a complete dossier always required?
Herbal Reference Standards (HRS)
  • Pharmacopoeial definition (Ph. Eur.)
  • Different types of HRS
  • Active and analytical markers
Q&A Session 1
 
EU GMP Annex 7 / GMP vs GACP
  • GACP Guideline
  • Herbal drugs: “Special APIs”? - EU GMP Part II
  • EU GMP Part I and Annex 7
  • Points to consider
Contaminants – A Risk based Approach„
  • Regulatory basis for risk-based testing for medicinal products with herbal ingredients
  • Procedure for the development of test concepts based on risk analyses
  • Different scopes of testing for release and re-testing of starting materials
  • Current examples of risk-based testing for contaminants:
    • Example 1: Pyrrolizidine Alkaloids
    • Example 2: Elemental Impurities (ICH Q3D)
    • Example 3: Aflatoxins
GMP Aspects for Extracts
  • Process Design
  • Qualification / validation
  • Extraction Solvents
  • Sampling and Testing Operations
Q&A Session 2
 
 
Programme - 9 November 2022
 
Current Requirements for the Microbiological Testing of HMPs
  • Typical microflora of medicinal plants
  • Requirements for the microbiological quality of herbal medicinal products
  • Microbiological test methods and proof of suitability
  • Decontamination methods for herbal starting materials
  • Experiences from authority inspections
Challenges in Stability Studies
  • Stability testing - general requirements
  • Characteristic of HMPs„
  • Particular aspects of HMPs:
    • Markers, methods, fingerprints, validation
    • Shelf-life / re-test date
    • OOS / OOT Results
Experiences from GMP Inspections / Audits
  • Quality management System (QMS)
  • Quality Risk Management (QRM)
  • Points to consider
Final Discussion
 
 
Post-Conference on Qualification & Validation Aspects for Cannabis (for Growing, Processing, Handling and Storage of Medical Cannabis) - 9 November 2022
 
Environmental Control and Monitoring
  • Solutions to control and monitor facilities in a safe, efficient and GMP-compliant manner
Process Validation & Equipment Qualification
  • Qualification of equipment / rooms / facilities / utilities (Systems)
  • Qualification / Validation Master Plan (VMP)
  • Principles of Quality Risk Management (QRM)
  • How to identify critical parameters
Case study: A New Production Facility for Cannabis
The presentation will provide insight in:
  • The main concept to set-up a Cannabis production facility
  • The zone concept, general layouts, hygienic aspects
  • How to integrate GMP requirements in the Project
  • How to deal with the authority
  • How to qualify suppliers
  • Realization of Qualification and Validation in practice
Experiences / Lessons learned
  • Changing Rooms – Air-locks - Zoning Concepts
  • Room Design and Room Separation
  • Drying Process – What needs to be done?
  • Points to consider
Final Discussion

This training/webinar cannot be booked. Send us your inquiry by using the following contact form.

To find alternative dates for this training/webinar or similar events please see the complete list of all events.

For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023